View by Specialty

Trending

UTI
November 11, 2024
3 min read
Save

WikiGuidelines group publishes first new UTI guidance in 14 years

Endocrinology News

SPONSORED CONTENT
Save
SPONSORED CONTENT
June 20, 2024
3 min read
Save

Patients prefer combined therapy for hypothyroidism, but data reveal few added benefits

Patients prefer combined therapy for hypothyroidism, but data reveal few added benefits

BOSTON — Most adults with hypothyroidism prefer combination therapy with liothyronine plus levothyroxine over levothyroxine alone, but most trials find combination therapy provides limited added benefit, according to two speakers.

SPONSORED CONTENT
June 20, 2024
3 min read
Save

FLOW, SURMOUNT-OSA trial symposia among highlights at ADA Scientific Sessions

FLOW, SURMOUNT-OSA trial symposia among highlights at ADA Scientific Sessions

Presentations on the SURMOUNT-OSA, FLOW, INHALE-3 and TIGHT trials are among the many highlights at the American Diabetes Association’s 84th Scientific Sessions.

Trending

UTI
November 11, 2024
3 min read
Save

WikiGuidelines group publishes first new UTI guidance in 14 years

SPONSORED CONTENT
June 19, 2024
3 min read
Save

‘A giant in the metabolic and hypertension field’: A tribute to George L. Bakris, MD

‘A giant in the metabolic and hypertension field’: A tribute to George L. Bakris, MD

Hypertension expert and longtime editorial board member for Healio | Cardiology and Healio | Endocrinology George L. Bakris, MD, died June 15, 2024, at the age of 72.

SPONSORED CONTENT
June 19, 2024
2 min read
Save

AMA: Nearly one in four physicians say prior authorization led to serious adverse events

AMA: Nearly one in four physicians say prior authorization led to serious adverse events

New survey results from the AMA illustrate the burden of prior authorization, with many physicians reporting that it leads to serious patient harms, delays care, reduces work productivity and more.

SPONSORED CONTENT
June 19, 2024
31 min listen
Save

Making an impact on chronic disease and physician health, with Sharon Horesh-Bergquist, MD

Making an impact on chronic disease and physician health, with Sharon Horesh-Bergquist, MD

In this episode, host Hansa Bhargava, MD, chats with Sharon Horesh-Bergquist, MD, about chronic disease, screenings and lifestyle and preventive medicine, as well as discussing physician wellness and burnout.

SPONSORED CONTENT
June 19, 2024
5 min read
Save

Q&A: What people with diabetes should know about preventing kidney stones

Q&A: What people with diabetes should know about preventing kidney stones

Susan Weiner, MS, RDN, CDN, CDCES, FADCES, talks with Melanie Betz, MS, RD, CSR, FNKF, FAND, about preventing kidney stones through diet and nutrition.

SPONSORED CONTENT
June 18, 2024
3 min read
Save

Metformin use during conception does not increase risk for adverse birth outcomes

Metformin use during conception does not increase risk for adverse birth outcomes

Maternal and paternal metformin use during conception did not increase the risk for adverse pregnancy outcomes, two studies in Annals of Internal Medicine showed.

SPONSORED CONTENT
June 18, 2024
3 min read
Save

USPSTF: Provide or refer youth with high BMI to behavioral interventions

USPSTF: Provide or refer youth with high BMI to behavioral interventions

In a final recommendation statement, the U.S. Preventive Services Task Force said that health care professionals should refer or provide youth aged 6 years and older with high BMI to intensive, comprehensive behavioral interventions.

SPONSORED CONTENT
June 18, 2024
3 min read
Save

NLA document issued to optimize screening, management of lipids in reproductive-age women

NLA document issued to optimize screening, management of lipids in reproductive-age women

The National Lipid Association has issued a clinical consensus statement on the management of dyslipidemia in women of reproductive potential, with a focus on considerations for pharmacologic options, a speaker reported.

SPONSORED CONTENT
June 18, 2024
3 min read
Save

Setmelanotide lowers BMI by 5% or more for most people with hypothalamic obesity

Setmelanotide lowers BMI by 5% or more for most people with hypothalamic obesity

Setmelanotide reduced BMI by at least 5% at 16 weeks among 89% of children and adults with hypothalamic obesity, according to findings from a phase 2 trial published in The Lancet Diabetes & Endocrinology.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails